Biohaven
Manufacturing · Connecticut, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
234 Church St, New Haven, Connecticut, 0...Phone Number
(203) 404-0410Website
www.biohaven.comRevenue
$541.5 MillionStock Symbol
BHVNIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
1
1
1
About Biohaven
Founded in 2022, Biohaven is a pharmaceutical company developing and commercializing life changing new therapies for people with debilitating diseases.Explore more
Biohaven Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biohaven your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Biohaven launches new products
Check if Biohaven has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Biohaven is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Biohaven
Earning: See what the market has to say on Biohaven recently announced quarterly report
Click to see if Biohaven had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Biohaven has new funding data
Biohaven, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Biohaven as Masked Content
Find more new buyers
Compare Similar Companies to Biohaven
Compare insights from companies similar to Biohaven, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Biohaven is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biohaven is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biohaven.
Biohaven Tech Stack
A closer look at the technologies used by Biohaven
See more technologies
Most Recent Scoops
Person-Based
Medical Research, Pharmaceuticals
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Biohaven News & Media
Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results
Biohaven to update clinical, regulatory, and operational progress at annual R&D Day at the upcoming Yale Innovation Summit on May 27, 2026. Advancement of high-value, late-stage priority programs: Pivotal epilepsy program with selective Kv7 ion channel activator, opakalim, with expected...Moderate Buy Rating Seen For Biohaven Ltd. (BHVN)
Biohaven Ltd. (NYSE:BHVN) is one of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The company’s stock price posted a 1.29% year-to-date increase, while it registered a 46.57% decline from a year ago. Based on an analyst consensus by TipRanks, Biohaven has an average price target of $21.44 with a moderate buy rating […]Canaccord Initiates Coverage of Biohaven Ltd. (BHVN) With a Buy Rating
Biohaven Ltd. (NYSE:BHVN) is one of the best low priced biotech stocks to invest in. On April 13, Canaccord initiated coverage of Biohaven Ltd. (NYSE:BHVN) with a Buy rating and set a $21 price target on the stock. The firm told investors in a research note that the company is in the process of developing novel […]Here is why Biohaven (BHVN) is Among the Top Healthcare Stocks Insiders Are Buying
Biohaven Ltd. (NYSE:BHVN) is one of the 8 Healthcare Stocks Insiders Are Buying. On April 2, 2026, Citi analyst Samantha Semenkow raised the price target on Biohaven Ltd. (NYSE:BHVN) to $17 from $14 and maintained a Buy rating. Samantha Semenkow said the firm sees attractive risk/reward at current levels ahead of 2026 catalysts, noting recent […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Biohaven
Sign Up For FreeTo access detailed company insights
Founded in 2022, Biohaven is a pharmaceutical company developing and commercializing life changing new therapies for people with debilitating diseases.... Read More
